Meanwhile, Liu et al. found that CNS5 and SPAG5 could affect hepatocellular carcinoma progression by mediating ubiquitination of β-catenin to reduce the expression of SCARA5 [9, 10]. Here, SCARA5 is linked to hepatocellular carcinoma.